Navigation Links
Anesthesia Drug To Bring Solace To The Depressed

A single dose of an anesthesia drug provided respite from depression for a small group of patients in whom other treatments had failed, report U.S. researchers//.

The researchers however indicated that the drug, ketamine, is unlikely to be put to use in the treatment of depression because of potential side effects, which includes psychosis. But the finding does signal a new direction for future research related to depression.

Currently available antidepressants take a long time to work. Ketamine,the anaesthetic drug, is effective not only for its speed, but also because it focuses on a new system in the brain.

"It's novel because all antidepressants that are currently available work on neurotransmitters that are monoamines like dopamine and serotonin. That's the focus of the current antidepressant armamentarium,” Dr. Richard A. Friedman, director of the psychopharmacology clinic at Cornell University's Medical Center in New York City said."Ketamine involves a particular system of the brain called glutamate. It's the main excitory neurotransmitter in the brain," he added.

Depression , a disabling condition, chronic in nature, affects almost 15 million Americans, that is, 7 percent of the adult U.S. population -- in any given year. 4 percent of these patients take their own lives, resulting in 30,000 suicides per year.

Unfortunately, 50% of patients with depression don't receive treatment and, of those who do, only 40% get the best. Some don’t get better even with the best treatment.

This is one of the first studies to analyse the effect of ketamine on depression in humans, the result of which is published in the August issue of the Archives of General Psychiatry. It was observed that depression improved within a day in 71 percent of the participants who were treated with ketamine, 29 percent of whom became nearly symptom-free in a day.

Short-term side effects, including perceptio n disturbances, usually disappeared before the antidepressant effect started to make an appearance. Participants were given a relatively low dose, so they were spared the more severe side effects.

Ketamine works by blocking the N-methyl-D-aspartic acid (NMDA) receptor, which receives signals for glutamate.

The researchers are now looking at other drugs to tackle depression.


'"/>




Related medicine news :

1. Bypass Heart Surgery Performed Without General Anesthesia
2. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
3. General Anesthesia For Heroin Detoxification Is No Good
4. Targeted Anesthesia Can Minimize Pain During Prostate Biopsy
5. Choice of Anesthesia in C-section
6. Dental Researchers Test No-Needle Anesthesia, No-Drilling Cavity Care
7. Obstetrical Anesthesia Equally Safe When Provided by CRNAs or Anesthesiologists
8. Two New Anesthesia Positions Promise to Ease Surgery Queue
9. Drug Found To Bring Relief For Individuals With Early Parkinson’
10. Improving Lighting Could Bring About A Change In Alzheimers Patients
11. Researchers Bring New Insight To Asthma And SABA Fills
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... March 27, 2017 , ... ... weight management program at Women’s Excellence will help patients lose weight and keep ... exam. The specialists at Women's Excellence will measure BMI, body fat composition, ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... nurses and supply chain professionals, will hold their first Northeast Regional AHVAP Meeting. ... Bundles.” , “Increasingly, supply chain and value analysis professionals have a ‘seat ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is ... complicated and require expert user knowledge. In a live webinar on April 11th ... simplified, yet highly accurate, determination of sodium. , It has long been known ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... with opioids alone responsible for over 33,000 of the 52,404 drug-related deaths in ... Bill (AB) 1512, which proposes a tax on prescription opioids to fund drug ...
(Date:3/25/2017)... ... March 25, 2017 , ... Getting earned media coverage meaningful for ... , All through the year, Garden Media aims to provide material helpful to ... influencers and pitching client’s key messages to gain coveted media placements, Garden ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing ... children, today reported financial results for the fourth ... and provided an update on its corporate activities. ... during the fourth quarter of 2016 through the ... study, and with our lead development candidate, PRX-OTC, ...
Breaking Medicine Technology: